Assembly Biosciences (ASMB) Tops Q2 EPS by 53c

Assembly Biosciences (NASDAQ: ASMB) reported Q2 EPS of ($0.20), $0.53 better than the analyst estimate of ($0.73). Revenue for the quarter came in at $13.37 million versus the consensus estimate of $8.6 million.

For earnings history and earnings-related data on Assembly Biosciences (ASMB) click here.

You May Also Be Interested In

• GameStop CEO Cohen buys 1.15M shares
• Novo Nordisk (NOVOB:DC) (NVO) PT Lowered to DKK245 at Deutsche Bank
• Indosat Tbk PT (ISAT:IJ) (PTITF) PT Raised to IDR35.10 at JPMorgan